Background
==========

Use of a nebulizer facilitates rapid administration of high doses of drug, which is desirable for patients presenting with acute severe asthma. Breath-enhanced jet nebulizers direct the patient**'**s air flow through the nebulizer handset during inhalation producing aerosol output with a more favorable respirable profile. SideStream Plus (SS+; Philips Respironics) and Nebutech (NB; Salter Labs) are breath-enhanced jet nebulizers, designed to produce a high delivered dose in a short treatment time. A previous *in vitro* characterization of delivered dose and droplet size distribution of arformoterol nebulized via the SS+ and the NB indicated that the SS+ performed favorably, compared with the NB.\[[@B1]\] We present results of an *in vitro* characterization of salbutamol sulphate (albuterol sulfate) delivery via the SS+ nebulizer and the NB nebulizer.

Method
======

Each nebulizer was filled with 3 ml salbutamol sulphate (5 mg/2.5 ml) and run with a driving flow of 8 l/min into a CEN adult tidal breathing pattern (Vt; 500 ml, 15 BPM, I:E ratio; 1:1). The nebulizers were run in triplicate to sputter point and sputter point plus 60 s. Dose delivered to a filter (delivered dose; DD), placed between the nebulizer and breathing emulator, was quantified using high performance liquid chromatography and expressed as a µl solution equivalent. A laser diffractor (Malvern Spraytec) was used to assess fine particle fraction (FPF) and mass median diameter (MMD) after 60 s nebulization time. Fine particle dose (FPD) was calculated (FPF x delivered dose).

Results
=======

The results are shown in Table [1](#T1){ref-type="table"}

  Experimental parameter              SS+    NB
  ----------------------------------- ------ ------
  MMD (µm)                            3.2    5.6
  FPF (%\<5 µm)                       74.2   43.7
  DD; Sputter (µl solution)           432    424
  FPD; Sputter (µl solution)          321    185
  DD; Sputter + 60 s (µl solution)    542    594
  FPD; Sputter + 60 s (µl solution)   402    260

Conclusion
==========

The total DD from the 2 nebulizers was comparable. Aerosol delivered via the SS+ nebulizer had a lower MMD and higher FPF, compared with that delivered via the NB nebulizer. This resulted in a 74% higher FPD delivered to sputter, and a 55% higher FPD delivered to sputter plus 60 s from the SS+ nebulizer compared with the NB nebulizer. The FPD represents respirable aerosol, and is therefore more clinically relevant than the DD. These results are consistent with previous work, and indicate that a high respirable dose of aerosol is produced by the SS+ nebulizer \[[@B1]\].
